Broderick Brian C Cyclerion Therapeutics, Inc. Transaction History

Broderick Brian C

  • $470 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 08, 2022
SELL
$1.56 - $2.99 $50,193 - $96,203
-32,175 Closed
0 $0
Q4 2019

Jan 15, 2020
SELL
$1.8 - $13.43 $1,339 - $9,991
-744 Reduced 2.26%
32,175 $88,000
Q2 2019

Jul 24, 2019
BUY
$9.6 - $22.85 $316,022 - $752,199
32,919 New
32,919 $377,000

Others Institutions Holding CYCN

# of Institutions
1
Shares Held
293K
Call Options Held
0
Put Options Held
0
View Full List

About Cyclerion Therapeutics, Inc.

CYCN Quotes by TradingView
  • Ticker CYCN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,479,800
  • Market Cap $139M
  • Description
  • Cyclerion Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovering, development, and commercialization of medicines for serious central nervous system (CNS) diseases. Its lead product candidate is CY6463, a CNS-penetrant, soluble guanylate cyclase (sGC) stimulator that is in Phase IIa trials for the treatment of...
More about CYCN
Track This Portfolio

Track Broderick Brian C Portfolio

Follow Broderick Brian C and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Broderick Brian C, based on Form 13F filings with the SEC.

News

Stay updated on Broderick Brian C with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email